Browsing by Funding agency "Consejería de Salud de la Junta de Andalucía"
Now showing items 1-1 of 1
-
Article
Ex vivo efect of JAK inhibition on JAK‑STAT1 pathway hyperactivation in patients with dominant‑negative STAT3 mutations
(SPRINGER, 2022)Purpose STAT1 gain-of-function (GOF) and dominant-negative (DN) STAT3 syndromes share clinical manifestations includ ing ...